July 31, 2020

Oncimmune Holdings results published from the ECLS study

The study is believed to be the largest randomised controlled trial for the detection of lung cancer using blood-based biomarkers and demonstrates a 36% reduction in later stage diagnoses of lung cancer..
Search

Funds

Search

Funds

July 31, 2020

FTSE 100

Funds